Long-term infusion of kallikrein attenuates renal injury in Dahl salt- sensitive rats

American Journal of Hypertension

Volumn 10, Issue 5 II SUPPL., 1997, Pages

  Uehara, Yoshio ^a   Hirawa, Nobuhito ^b   Numabe, Atsushi ^c   Kawabata, Yukari ^a   Ikeda, Toshio ^b   Gomi, Tomoko ^b   Gotoh, Atsuo ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NTT CORPORATION   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

angiotensin converting enzyme inhibitor; arterial injury; Dahl salt sensitive rats; glomerulosclerosis; Kallikrein; kinin; prostaglandin; renal injury

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; KALLIKREIN; KININ; NITRIC OXIDE; PROSTAGLANDIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; CONFERENCE PAPER; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HYPERTENSION; KALLIKREIN KININ SYSTEM; KIDNEY INJURY; NONHUMAN; PRIORITY JOURNAL; RAT; SALT INTAKE;

EID: 0030920338     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(97)90012-1     Document Type: Conference Paper

References (23)

1. Margolius HS. Tissue kallikreins and kinins: regulation and roles in hypertensive and diabetic disease. Annu Rev Pharmacol Toxicol. 29:1989;343-364.
2. Chen K, Zhang X, Dunham EW, Zimmerman BG. Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension. Hypertension. 27:1996;85-89.
3. Majima M, Katori M. Approaches to the development of novel antihypertensive drugs: crucial role of the renal kallikrein-kinin system. Trends Pharmacol Sci. 16:1995;239-246.
4. Ferri C, Bellini C, Carlomagno A, et al. Urinary kallikrein and salt sensitivity in essential hypertensive males. Kidney Int. 46:1994;780-788.
5. M'Buyamba-Kabangu JR, Amery A, Lijnen P. Differences between black and white persons in blood pressure and related biological variables. J Hum Hypertens. 8:1994;163-170.
6. Bonner G, Thieven B, Rutten H, et al. Renal kallikrein is a determinant of salt sensitivity. J Hypertens. 11:((suppl 5)):1993;S210-S211.
7. Bellini C, Ferri C, Piccoli A, et al. The influence of salt sensitivity on the blood pressure response to exogenous kallikrein in essential hypertensive patients. Nephron. 65:1993;28-35.
8. Majima M, Yoshida O, Mihara H, et al. High sensitivity to salt in kininogen-deficient brown Norway Katholiek rats. Hypertension. 22:1993;705-714.
9. Ideishi M, Miura S, Sakai T, et al. Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats. J Hypertens. 12:1994;653-661.
10. Bouhnik J, Richoux JP, Huang H, et al. Hypertension in Dahl salt-sensitive rats: biochemical and immunohistochemical studies. Clin Sci. 83:1992;13-22.
11. Ishiguro T, Shimamoto K, Ura N, et al. The pathophysiological role of renal dopamine and kallikrein in deoxycorticosterone acetate (DOCA)-salt treated rats. Clin Exp Hypertens [A]. 17:1995;1287-1299.
12. Katori M, Majima M, Mohsin SS, et al. Essential role of kallikrein-kinin system in suppression of blood pressure rise during the developmental stage of hypertension induced by deoxycorticosterone acetate-salt in rats. Agents Actions. 38:((pt 3)):1992;235-242.
13. Summerson JH, Bell RA, Konen JC. Racial differences in the prevalence of microalbuminuria in hypertension. Am J Kidney Dis. 26:1995;577-579.
14. Calhoun DA, Oparil S. Racial differences in the pathogenesis of hypertension. Am J Med Sci. 10:((suppl 1)):1995;S86-S90.
15. Uehara Y, Numabe A, Hirawa N, et al. Antihypertensive effects of cicletanine and renal protection in Dahl salt-sensitive rats. J Hypertens. 9:1991;719-728.
16. Hirawa N, Uehara Y, Kawabata Y, et al. Subpressor dose of angiotensin II increases susceptibility to the haemodynamic injury of blood pressure in Dahl salt-sensitive rats. J Hypertens. 13:1995;81-90.
17. Sharma JN, Amrash SS, Noor AR. Suppression of hypotensive response of captopril and enalapril by the kallikrein inhibitor aprotinin in spontaneously hypertensive rats. Pharmacology. 50:1995;363-369.
18. Hirawa N, Uehara Y, Kawabata Y, et al. Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitor in Dahl salt-sensitive rats. J Hypertens. 12:1994;909-918.
19. Wang C, Chao L, Chao J. Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats. J Clin Invest. 95:1995;1710-1716.
20. Xiong W, Chao J, Chao L. Muscle delivery of human kallikrein gene reduces blood pressure in hypertensive rats. Hypertension. 25:1995;715-719.
21. Uehara Y, Hirawa N, Kawabata Y, et al. Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats. Hypertension. 24:1994;770-778.
22. Kizuki K, Kitagawa A, Takahashi M, et al. Immunohistochemical localization of kallikrein within the prolactin-producing cells of the rat anterior pituitary gland. J Endocrinol. 127:1990;317-323.
23. Kitagawa A, Kizuki K, Moriya H, et al. Kallikrein- and prolactin-producing cells in the rat anterior pituitary are the same. J Biochem. 108:1990;971-975.